Drug Profile
Pegfilgrastim biosimilar - Dr Reddy's Laboratories
Alternative Names: DRL_PG; Peg-grafeel; Recombinant pegylated human granulocyte colony stimulating factor - Dr Reddy's LaboratoriesLatest Information Update: 25 Nov 2021
Price :
$50
*
At a glance
- Originator Dr Reddys Laboratories
- Class Antineoplastics; Chemoprotectants; Granulocyte colony-stimulating factors; Polyethylene glycols; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor receptor agonists; Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Neutropenia(In volunteers) in USA (SC, Injection)
- 28 Feb 2014 Phase-I clinical trials in Neutropenia (In volunteers) in USA (SC)
- 10 May 2011 Launched for Neutropenia in India (SC)